임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상완료· Essential HypertensionA Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
리드: 대웅제약
- 3상완료· HypertensionEfficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
리드: 대웅제약
- 3상완료· Moderately to Severely Active Rheumatoid ArthritisA Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis
리드: 셀트리온
- 3상완료· Chronic Low-back PainA Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
리드: 한미약품
- 3상완료· Parenteral NutritionClinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition
리드: 유한양행
- 3상완료· Gastro Oesophageal Reflux DiseaseStudy Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
협력: 대웅제약
- 3상완료· HypertensionA Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
리드: 한미약품
- 3상완료· Helicobacter Pylori InfectionStudy to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
리드: 대웅제약
- 3상완료· Essential HypertensionClinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
리드: 종근당
- 3상완료· Essential HypertensionClinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
리드: 종근당
- 3상완료· Gastric UlcerA Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
리드: 한미약품
- 3상완료· Type 2 Diabetes MellitusTo Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM
리드: JW중외제약
- 3상완료· Type 2 Diabetes MellitusTo Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
리드: JW중외제약
- 3상완료· Moderate to Severe Chronic Plaque PsoriasisTo Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
리드: 셀트리온
- 3상완료· Type 2 DiabetesThe Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes
리드: 종근당
- 3상완료· Rheumatoid ArthritisA Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
리드: 셀트리온
- 3상완료· HypertensionA Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
리드: 한미약품
- 3상완료· Reflux EsophagitisThe Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
리드: 대웅제약
- 3상완료· HypertensionClinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients
리드: 한미약품
- 3상완료· DyslipidemiaTo Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension
리드: JW중외제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
리드: 대웅제약
- 3상완료· Diabetic Macular Edema (DME)Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
리드: 셀트리온
- 3상완료· Postmenopausal Women With OsteoporosisA Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
리드: 셀트리온
- 3상완료· T2DM (Type 2 Diabetes Mellitus)Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
리드: 대웅제약
- 3상완료· Partial SeizureRandomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS
리드: SK바이오팜
- 3상완료· T2DM (Type 2 Diabetes Mellitus)The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
리드: 대웅제약
- 3상완료· Chronic Spontaneous UrticariaTo Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
리드: 셀트리온
- 3상완료· Postmenopausal OsteoporosisA Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis
리드: 삼성바이오에피스
- 3상완료· T2DM (Type 2 Diabetes Mellitus)The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
리드: 대웅제약
- 3상완료· T2DM (Type 2 Diabetes Mellitus)The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
리드: 대웅제약
- 3상완료· HypertensionClinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
리드: 한미약품
- 3상완료· HypertensionClinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
리드: 한미약품
- 3상완료· Moderate to Severe Glabellar LinesDWP450 for Treating Moderate to Severe Glabellar Lines
리드: 대웅제약
- 3상완료· Primary HypercholesterolemiaEfficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
리드: 한미약품
- 3상완료· Neovascular Age-related Macular DegenerationA Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
리드: 삼성바이오에피스
- 3상완료· Acute GastritisStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
리드: 대웅제약
- 3상완료· Benign Masseteric HypertrophyEfficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
리드: 대웅제약
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.